Cencora

NYSE: COR
New York Stock Exchange
Healthcare Medical Distribution
Global Rank
#373
Country Rank
#186
Market Cap
56.66 B
Price
292.32
Change (%)
0.61%
Volume
885,014

Cencora's latest marketcap:

56.66 B

As of 06/26/2025, Cencora's market capitalization has reached $56.66 B. According to our data, Cencora is the 373th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 56.66 B
Revenue (ttm) 310.23 B
Net Income (ttm) 1.69 B
Shares Out 193.82 M
EPS (ttm) 8.59
Forward PE 17.69
Ex-Dividend Date 05/16/2025
Earnings Date 07/30/2025
Market Cap Chart
Data Updated: 06/26/2025

Cencora's yearly market capitalization.

Cencora has seen its market value grow from $1.57 B to $56.66 B since 1998, representing a total increase of 3,497.59% and an annual compound growth rate (CAGR) of 14.48%.
Date Market Cap Change (%) Global Rank
06/26/2025 $56.66 B 30.83% 373
12/31/2024 $43.43 B 5.35% 441
12/29/2023 $41.22 B 20.95% 432
12/30/2022 $34.08 B 23.22% 488
12/31/2021 $27.66 B 38.52% 733
12/31/2020 $19.97 B 14.05% 874
12/31/2019 $17.51 B 11.03% 811
12/31/2018 $15.77 B -21.26% 727
12/29/2017 $20.02 B 16.36% 657
12/30/2016 $17.21 B -19.3% 625

Company Profile

About Cencora, Inc.

Cencora, Inc. is a global leader in pharmaceutical sourcing and distribution, operating in the United States and internationally. Formerly known as AmerisourceBergen Corporation, the company rebranded to Cencora, Inc. in August 2023.

Business Segments

U.S. Healthcare Solutions

  • Distributes pharmaceuticals, over-the-counter healthcare products, and home healthcare supplies to hospitals, pharmacies, clinics, and long-term care facilities.
  • Provides pharmacy management, staffing, consulting, and supply management software.
  • Offers packaging solutions, clinical trial support, and commercialization services for biotech and pharmaceutical manufacturers.
  • Supplies animal health products, including pharmaceuticals, vaccines, and diagnostics for companion and production animals.
  • Distributes plasma, blood products, injectables, and specialty pharmaceuticals to healthcare providers.

International Healthcare Solutions

  • Provides global pharmaceutical wholesale and commercialization services.
  • Distributes healthcare products to pharmacies, doctors, hospitals, and health centers.
  • Offers specialty transportation and logistics for the biopharmaceutical industry.

Company Background

Founded in 1871, Cencora, Inc. is headquartered in Conshohocken, Pennsylvania, and continues to play a pivotal role in the healthcare supply chain.

Frequently Asked Questions

  • What is Cencora's (COR) current market cap?
    As of 06/26/2025, Cencora (including the parent company, if applicable) has an estimated market capitalization of $56.66 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Cencora global market capitalization ranking is approximately 373 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.